Insurance - Specialty
Compare Stocks
2 / 10Stock Comparison
HIPO vs CB
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Property & Casualty
HIPO vs CB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Insurance - Specialty | Insurance - Property & Casualty |
| Market Cap | $713M | $125.61B |
| Revenue (TTM) | $480M | $59.77B |
| Net Income (TTM) | $113M | $10.31B |
| Gross Margin | 40.5% | 29.4% |
| Operating Margin | 24.2% | 21.8% |
| Forward P/E | 114.1x | 11.9x |
| Total Debt | $52M | $22.19B |
| Cash & Equiv. | $250M | $2.47B |
HIPO vs CB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Hippo Holdings Inc. (HIPO) | 100 | 9.6 | -90.4% |
| Chubb Limited (CB) | 100 | 221.0 | +121.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HIPO vs CB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HIPO carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 25.9%, EPS growth 235.4%, 3Y rev CAGR 57.6%
- Lower volatility, beta 1.40, Low D/E 12.0%, current ratio 0.35x
- 25.9% revenue growth vs CB's 6.5%
CB is the clearest fit if your priority is long-term compounding.
- 189.4% 10Y total return vs HIPO's -90.5%
- Lower P/E (11.9x vs 114.1x)
- Combined ratio 0.8 vs HIPO's 0.9 (lower = better underwriting)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.9% revenue growth vs CB's 6.5% | |
| Value | Lower P/E (11.9x vs 114.1x) | |
| Quality / Margins | Combined ratio 0.8 vs HIPO's 0.9 (lower = better underwriting) | |
| Stability / Safety | Lower D/E ratio (12.0% vs 27.8%) | |
| Dividends | 1.2% yield; 9-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +14.0% vs CB's +12.7% | |
| Efficiency (ROA) | 6.0% ROA vs CB's 4.0%, ROIC 22.8% vs 10.8% |
HIPO vs CB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HIPO vs CB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HIPO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CB is the larger business by revenue, generating $59.8B annually — 124.6x HIPO's $480M. HIPO is the more profitable business, keeping 23.4% of every revenue dollar as net income compared to CB's 17.2%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $480M | $59.8B |
| EBITDAEarnings before interest/tax | $116M | $13.3B |
| Net IncomeAfter-tax profit | $113M | $10.3B |
| Free Cash FlowCash after capex | $50M | $13.5B |
| Gross MarginGross profit ÷ Revenue | +40.5% | +29.4% |
| Operating MarginEBIT ÷ Revenue | +24.2% | +21.8% |
| Net MarginNet income ÷ Revenue | +23.4% | +17.2% |
| FCF MarginFCF ÷ Revenue | +10.4% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.2% | +7.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +114.1% | +28.0% |
Valuation Metrics
Evenly matched — HIPO and CB each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, HIPO trades at a 1% valuation discount to CB's 12.5x P/E. On an enterprise value basis, HIPO's 8.1x EV/EBITDA is more attractive than CB's 10.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $713M | $125.6B |
| Enterprise ValueMkt cap + debt − cash | $515M | $145.3B |
| Trailing P/EPrice ÷ TTM EPS | 12.34x | 12.51x |
| Forward P/EPrice ÷ next-FY EPS est. | 114.13x | 11.89x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.46x |
| EV / EBITDAEnterprise value multiple | 8.14x | 10.89x |
| Price / SalesMarket cap ÷ Revenue | 1.52x | 2.10x |
| Price / BookPrice ÷ Book value/share | 1.63x | 1.60x |
| Price / FCFMarket cap ÷ FCF | 78.35x | 8.64x |
Profitability & Efficiency
HIPO leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
HIPO delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $14 for CB. HIPO carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to CB's 0.28x. On the Piotroski fundamental quality scale (0–9), CB scores 7/9 vs HIPO's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +27.4% | +13.6% |
| ROA (TTM)Return on assets | +6.0% | +4.0% |
| ROICReturn on invested capital | +22.8% | +10.8% |
| ROCEReturn on capital employed | +6.9% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.12x | 0.28x |
| Net DebtTotal debt minus cash | -$198M | $19.7B |
| Cash & Equiv.Liquid assets | $250M | $2.5B |
| Total DebtShort + long-term debt | $52M | $22.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 18.07x |
Total Returns (Dividends Reinvested)
CB leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CB five years ago would be worth $19,590 today (with dividends reinvested), compared to $1,107 for HIPO. Over the past 12 months, HIPO leads with a +14.0% total return vs CB's +12.7%. The 3-year compound annual growth rate (CAGR) favors CB at 18.6% vs HIPO's 14.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.6% | +4.1% |
| 1-Year ReturnPast 12 months | +14.0% | +12.7% |
| 3-Year ReturnCumulative with dividends | +48.1% | +66.7% |
| 5-Year ReturnCumulative with dividends | -88.9% | +95.9% |
| 10-Year ReturnCumulative with dividends | -90.5% | +189.4% |
| CAGR (3Y)Annualised 3-year return | +14.0% | +18.6% |
Risk & Volatility
CB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CB is the less volatile stock with a -0.01 beta — it tends to amplify market swings less than HIPO's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CB currently trades 93.1% from its 52-week high vs HIPO's 70.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | -0.01x |
| 52-Week HighHighest price in past year | $38.98 | $345.67 |
| 52-Week LowLowest price in past year | $19.92 | $264.10 |
| % of 52W HighCurrent price vs 52-week peak | +70.3% | +93.1% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 43.7 |
| Avg Volume (50D)Average daily shares traded | 113K | 1.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates HIPO as "Buy" and CB as "Buy". Consensus price targets imply 7.0% upside for CB (target: $344) vs 3.6% for HIPO (target: $28). CB is the only dividend payer here at 1.18% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $28.38 | $344.33 |
| # AnalystsCovering analysts | 6 | 43 |
| Dividend YieldAnnual dividend ÷ price | — | +1.2% |
| Dividend StreakConsecutive years of raises | — | 9 |
| Dividend / ShareAnnual DPS | — | $3.80 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +2.9% |
HIPO leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CB leads in 2 (Total Returns, Risk & Volatility). 1 tied.
HIPO vs CB: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HIPO or CB a better buy right now?
For growth investors, Hippo Holdings Inc.
(HIPO) is the stronger pick with 25. 9% revenue growth year-over-year, versus 6. 5% for Chubb Limited (CB). Hippo Holdings Inc. (HIPO) offers the better valuation at 12. 3x trailing P/E (114. 1x forward), making it the more compelling value choice. Analysts rate Hippo Holdings Inc. (HIPO) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HIPO or CB?
On trailing P/E, Hippo Holdings Inc.
(HIPO) is the cheapest at 12. 3x versus Chubb Limited at 12. 5x. On forward P/E, Chubb Limited is actually cheaper at 11. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HIPO or CB?
Over the past 5 years, Chubb Limited (CB) delivered a total return of +95.
9%, compared to -88. 9% for Hippo Holdings Inc. (HIPO). Over 10 years, the gap is even starker: CB returned +189. 4% versus HIPO's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HIPO or CB?
By beta (market sensitivity over 5 years), Chubb Limited (CB) is the lower-risk stock at -0.
01β versus Hippo Holdings Inc. 's 1. 40β — meaning HIPO is approximately -26024% more volatile than CB relative to the S&P 500. On balance sheet safety, Hippo Holdings Inc. (HIPO) carries a lower debt/equity ratio of 12% versus 28% for Chubb Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — HIPO or CB?
By revenue growth (latest reported year), Hippo Holdings Inc.
(HIPO) is pulling ahead at 25. 9% versus 6. 5% for Chubb Limited (CB). On earnings-per-share growth, the picture is similar: Hippo Holdings Inc. grew EPS 235. 4% year-over-year, compared to 13. 3% for Chubb Limited. Over a 3-year CAGR, HIPO leads at 57. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HIPO or CB?
Chubb Limited (CB) is the more profitable company, earning 17.
2% net margin versus 12. 3% for Hippo Holdings Inc. — meaning it keeps 17. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CB leads at 21. 8% versus 13. 5% for HIPO. At the gross margin level — before operating expenses — HIPO leads at 50. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HIPO or CB more undervalued right now?
On forward earnings alone, Chubb Limited (CB) trades at 11.
9x forward P/E versus 114. 1x for Hippo Holdings Inc. — 102. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CB: 7. 0% to $344. 33.
08Which pays a better dividend — HIPO or CB?
In this comparison, CB (1.
2% yield) pays a dividend. HIPO does not pay a meaningful dividend and should not be held primarily for income.
09Is HIPO or CB better for a retirement portfolio?
For long-horizon retirement investors, Chubb Limited (CB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
01), 1. 2% yield, +189. 4% 10Y return). Both have compounded well over 10 years (CB: +189. 4%, HIPO: -90. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HIPO and CB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HIPO is a small-cap high-growth stock; CB is a mid-cap deep-value stock. CB pays a dividend while HIPO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.